Skip to content

David against Goliath - Use of microbubbles and more to improve the diagnostics of Giant Cell Arteritis. A pilot study

David against Goliath - Use of microbubbles and more to improve the diagnostics of Giant Cell Arteritis. A pilot study - David against Goliath - Use of microbubbles and more for GCA

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON56660
Enrollment
20
Registered
2023-10-20
Start date
2024-06-20
Completion date
Unknown
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Giant cell arteritis

Interventions

Ultrasound for GCA with and without CEUS, SMI en 3D ultrasound.&nbsp

Sponsors

Ziekenhuis Groep Twente (ZGT)
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - patients and healthy controls 50 years or older - no atherosclerosis with ischaemic complications - sufficient understanding of the dutch language Specificaly for patients: - diagnosis RCA according to ACR/EULAR criteria 2022 - visible abnormalities consistent with RCA on conventional ultrasound sonography

Exclusion criteria

Exclusion criteria: - legal incapacity - use of corticosteroids for > 7 days at a dose of > 5 mg per day at the time of inclusion or in the month prior to the ultrasound - contraindication for the use of microbubbles or 3D ultrasound

Design outcomes

Primary

MeasureTime frame
The primary endpoint will be the diagnostic value of the techniques, calculated using the sensitivity and specificity, including the AUC, the positive predictive value and negative predictive value.

Secondary

MeasureTime frame
The secondary endpoints are the interobserver variability (calculated using Cohen's kappa dichotomous outcomes and the intraclass coefficient for continuous outcomes), and the duration in minutes.

Countries

Netherlands

Contacts

Public ContactC Alves

Ziekenhuis Groep Twente (ZGT)

reumatologie@zgt.nl0887083403

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Mar 20, 2026